Enhancing postpartum cardiometabolic health for women with previous gestational diabetes: Next steps and unanswered questions for pharmacological and lifestyle strategies.
The article discusses the impact of gestational diabetes mellitus (GDM) on women's long-term cardiometabolic health, highlighting the increased risk of developing type 2 diabetes (T2D) and cardiovascular disease (CVD) postpartum. It explores the effectiveness of lifestyle modifications and pharmacological interventions, such as incretin-based therapies, in reducing these risks. The study emphasizes the need for further research to address unanswered questions, including the impact of combined interventions on foetal outcomes, psychological well-being, and the influence of genetic factors, while also advocating for more diverse and culturally sensitive approaches in future studies.